Hey JR56 - really nice to have someone on this forum who seems pretty switched on when it comes to the ins and outs of IIQ's technologies.
Would love to hear more from you about your views on their various technologies and any other views/concerns you may have? I know the previous Chief Scientist Peter French described SubB2m as the best thing he had seen in his 40 year cancer research career and the CEO has waxed lyrical about SubB2M to me also; the initial Ovarian/Breast results in Feb 21 seemed to back up their excitement.
Love to hear about what you think about their technologies - in particular SubB2M and Exonet and the strategy for getting them to market?
cheers in advance!
Ann: Appendix 4C & Quarterly Activities Report, page-13
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
-0.010(1.67%) |
Mkt cap ! $65.06M | |||
| Open | High | Low | Value | Volume |
| 59.5¢ | 59.5¢ | 58.0¢ | $4.527K | 7.767K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 38600 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 198 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |